Anatera Stungulyf, lausn 10 % আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

anatera stungulyf, lausn 10 %

alcon nordic a/s - fluoresceinum natríum - stungulyf, lausn - 10 %

Alcaine Augndropar, lausn 5 mg/ml আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

alcaine augndropar, lausn 5 mg/ml

alcon nordic a/s - proxymetacainum hýdróklóríð - augndropar, lausn - 5 mg/ml

Mydriacyl Augndropar, lausn 10 mg/ml আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

mydriacyl augndropar, lausn 10 mg/ml

alcon nordic a/s - tropicamidum inn - augndropar, lausn - 10 mg/ml

Oculac Augndropar, lausn 5 % আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

oculac augndropar, lausn 5 %

alcon nordic a/s - povidonum k25 - augndropar, lausn - 5 %

Oculac án rotvarnar Augndropar, lausn 5 % আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

oculac án rotvarnar augndropar, lausn 5 %

alcon nordic a/s - povidonum k25 - augndropar, lausn - 5 %

Vigamox (Moxifloxacin Alcon) Augndropar, lausn 5 mg/ml আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

vigamox (moxifloxacin alcon) augndropar, lausn 5 mg/ml

novartis healthcare a/s - moxifloxacinum hýdróklóríð - augndropar, lausn - 5 mg/ml

Oculac (Heilsa) Augndropar, lausn í stakskammtaíláti 50 mg/ml আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

oculac (heilsa) augndropar, lausn í stakskammtaíláti 50 mg/ml

heilsa ehf. - povidone k25 - augndropar, lausn í stakskammtaíláti - 50 mg/ml

Cyclogyl 1% Augndropar, lausn 10 mg/ ml আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

cyclogyl 1% augndropar, lausn 10 mg/ ml

alcon nordic a/s - cyclopentolatum hýdróklóríð - augndropar, lausn - 10 mg/ ml

Fulvestrant Mylan ইউরোপীয় ইউনিয়ন - আইসল্যান্ডীয় - EMA (European Medicines Agency)

fulvestrant mylan

mylan pharmaceuticals limited - fulvestrant - brjóstakrabbamein - innkirtla meðferð - fulvestrant er ætlað fyrir meðferð estrógen viðtaka jákvætt, á staðnum háþróaður eða brjóstakrabbamein í tíðahvörf konur:ekki áður meðhöndluð með annarra meðferð, eðameð sjúkdómur bakslag eða á eftir viðbótar anti-estrógen meðferð, eða sjúkdóms á andestrógeni meðferð.

Fulvestrant Teva Stungulyf, lausn í áfylltri sprautu 250 mg আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

fulvestrant teva stungulyf, lausn í áfylltri sprautu 250 mg

teva b.v.* - fulvestrantum inn - stungulyf, lausn í áfylltri sprautu - 250 mg